Abstract:Background: Sepsis is a life-threatening organ dysfunction caused by abnormal immune responses to various, predominantly bacterial, infections. Different bacterial infections lead to substantial variation in disease manifestation and therapeutic strategies. However, the underlying cellular heterogeneity and mechanisms involved remain poorly understood. Methods: Multiple bulk transcriptome datasets from septic patients with 12 types of bacterial infections were integrated to identify signature genes for each infection. Signature genes were mapped onto an integrated large single-cell RNA (scRNA) dataset from septic patients, to identify subsets of cells associated with different sepsis types, and multiple omics datasets were combined to reveal the underlying molecular mechanisms. In addition, an scRNA dataset and spatial transcriptome data were used to identify signaling pathways in sepsis-related cells. Finally, molecular screening, optimization, and de novo design were conducted to identify potential targeted drugs and compounds. Results: We elucidated the cellular heterogeneity among septic patients with different bacterial infections. In Escherichia coli (E. coli) sepsis, 19 signature genes involved in epigenetic regulation and metabolism were identified, of which DRAM1 was demonstrated to promote autophagy and glycolysis in response to E. coli infection. DRAM1 upregulation was confirmed in an independent sepsis cohort. Further, we showed that DRAM1 could maintain survival of a pro-inflammatory monocyte subset, C10_ULK1, which induces systemic inflammation by interacting with other cell subsets via resistin and integrin signaling pathways in blood and kidney tissue, respectively. Finally, retapamulin was identified and optimized as a potential drug for treatment of E. coli sepsis targeting the signature gene, DRAM1, and inhibiting E. coli protein synthesis. Several other targeted drugs were also identified in other types of sepsis, including nystatin targeting C1QA in Neisseria sepsis and dalfopristin targeting CTSD in Streptococcus viridans sepsis. Conclusion: Our study provides a comprehensive overview of the cellular heterogeneity and underlying mechanisms in septic patients with various bacterial infections, providing insights to inform development of stratified targeted therapies for sepsis.

Differential Gene Expression in Gram-negative and Gram-positive Sepsis

Insights into the Molecular Mechanisms in Sepsis with Microarray Technology.

Identification of Potential Transcriptional Biomarkers Differently Expressed in Both S. aureus- and E. coli-Induced Sepsis via Integrated Analysis

Differential Gene Sets Profiling in Gram-Negative and Gram-Positive Sepsis

Comprehensive Analysis of Common Different Gene Expression Signatures in the Neutrophils of Sepsis.

Master Genes and Co-Expression Network Analysis in Peripheral Blood Mononuclear Cells of Patients with Gram-Positive and Gram-Negative Sepsis

Differential Expression Profile of Long Non-Coding RNAs from Gr-1+ CD11b+ Myeloid Cells in Response to Sepsis in Mice (INM2P.424)

Classification of subtypes and identification of dysregulated genes in sepsis

Gram-negative bacterial infection causes aggravated innate immune response in sepsis: Studies from clinical samples and cellular models

Commonly Expressed Key Transcriptomic Profiles of Sepsis in the Human Circulation and Brain Via Integrated Analysis.

Key genes affecting outcome of sepsis: identification using weighted gene co-expression network analysis

Identifying Six Chromatin Remodeling-related Genes As Diagnostic Biomarkers in Sepsis Using Bioinformatic Analyses

Gene silencing in sepsis

Single-cell RNA sequencing and transcriptomic analysis reveal key genes and regulatory mechanisms in sepsis

Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia

Identification of Potential Biomarkers and Immune Features of Sepsis Using Bioinformatics Analysis

Screening and Identification of Key Gene in Sepsis Development: Evidence from Bioinformatics Analysis.

Deciphering the molecular and cellular atlas of immune cells in septic patients with different bacterial infections

Identification of key biomarkers and therapeutic targets in sepsis through coagulation-related gene expression and immune pathway analysis

Novel Biomarkers Associated with Sepsis

Insights from the Analysis of the Sepsis Dataset: Understanding the Immune Dynamics and Molecular Pathways in Sepsis